Keyphrases
Muscular Dystrophy
100%
Inflammatory Fibrosis
100%
Regeneration
100%
Dystrophin
63%
Sarcoglycan
54%
Cardiac Function
36%
Fibrosis
27%
Skeletal muscle
27%
Hydroxyproline Content
18%
Muscle Pathology
18%
Genetic Modifiers
18%
Duchenne muscular Dystrophy
18%
Cardiac muscle
18%
Muscle Disease
18%
Null Model
9%
Progressive Weakness
9%
Cardiac Pathology
9%
Evans Blue Dye
9%
Mild Forms
9%
Dye Uptake
9%
Strength Function
9%
Repeat Contractions
9%
Background Strain
9%
Genetic Loci
9%
Dilated Cardiomyopathy
9%
Echocardiography
9%
Genetic Pathways
9%
Cardiac Fibrosis
9%
Muscle Strength
9%
Phenotypic Variation
9%
Binding Protein
9%
Gene mutation
9%
Cardiomyopathy
9%
Disease Process
9%
LTBP4
9%
Mdx Mice
9%
In Vivo Methods
9%
Reinforced
9%
Muscle Function
9%
Therapeutic Intervention
9%
Pathological Features
9%
Severe Disease
9%
Human Disease
9%
Single-point mutation
9%
Plasma Membrane
9%
Mouse Model
9%
Null Mice
9%
Less Invasive
9%
Biochemistry, Genetics and Molecular Biology
Dystrophin
100%
Sarcoglycan
85%
Heart Function
57%
Genetics
42%
Skeletal Muscle
42%
Glycoprotein
42%
Mouse Model
14%
Binding Protein
14%
Evans Blue
14%
Muscle Function
14%
Knockout Mouse
14%
Muscle Strength
14%
Gene Locus
14%
Gene Mutation
14%
Cell Membrane
14%